Overall, our findings highlight the widespread up-regulation and functional significance of Cullin genes in CRC, with CUL5 and CUL7 emerging as key contributors to tumor progression and potential biomarkers or therapeutic targets. This evidence concerns the gene CUL5 and neoplasm.